Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,725,986
+$314,082 QoQ
Shares Held
28,996
+2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,196
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTRUST BANK NA holds $44,865,794 across 13 Drug Manufacturers - General names. MRK ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,489 | $13,780,251 | |
| 2 | ABBV |
AbbVie Inc.
|
26,654 | $6,707,212 | |
| 3 | JNJ |
Johnson & Johnson
|
24,382 | $6,192,296 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
28,996 | $3,725,986 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
24,402 | $3,082,948 | |
| 6 | AMGN |
Amgen Inc
|
7,840 | $2,839,020 | |
| 7 | AZN |
Astrazeneca PLC
|
10,427 | $1,977,167 | |
| 8 | NVS |
Novartis AG
|
11,153 | $1,747,897 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,725,986 | 28,996 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,411,904 | 28,364 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,548,449 | 24,211 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,964,129 | 23,402 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,776,508 | 22,442 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,438,778 | 27,170 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,962,513 | 29,780 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,618,929 | 31,868 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,168,717 | 33,673 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,299,722 | 32,586 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,482,861 | 31,947 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,595,219 | 34,922 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,243,005 | 36,771 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,898,767 | 36,646 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,739,014 | 33,700 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,748,691 | 31,917 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,891,820 | 31,719 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $2,410,874 | 29,383 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,928,492 | 25,163 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,048,323 | 27,271 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,979,246 | 25,450 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,742,928 | 22,609 | Shares | Sole | 2021-06-02 | |
| 2020-12-31 | $2,284,672 | 27,930 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,315,549 | 27,915 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,198,802 | 28,434 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,286,501 | 29,718 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||